Evidence-based renal replacement therapy for acute kidney injury

A. Zarbock, K. Singbartl, J. A. Kellum

Research output: Contribution to journalComment/debate

15 Citations (Scopus)

Abstract

Acute kidney injury (AKI) with the subsequent need for renal replacement therapy (RRT) represents a persistent challenge, arising in 4-5% in critically-ill patients, and remains associated with a high mortality (60%) and morbidity. As AKI is an independent risk factor for poor prognosis, appropriate management of patients with AKI becomes of utmost importance. Complications of AKI can be treated with different forms of RRT, such as continuous venovenous hemofiltration or intermittent hemodialysis. However, the timing of the initiation, the modality, and the dose of RRT are still controversial and the subject of ongoing clinical trials. This review presents and discusses currently available data regarding the use of RRT in critically-ill patients with AKI.

Original languageEnglish (US)
Pages (from-to)135-139
Number of pages5
JournalMinerva Anestesiologica
Volume75
Issue number3
StatePublished - Mar 2009

Fingerprint

Renal Replacement Therapy
Acute Kidney Injury
Critical Illness
Hemofiltration
Renal Dialysis
Clinical Trials
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

Cite this

Zarbock, A., Singbartl, K., & Kellum, J. A. (2009). Evidence-based renal replacement therapy for acute kidney injury. Minerva Anestesiologica, 75(3), 135-139.
Zarbock, A. ; Singbartl, K. ; Kellum, J. A. / Evidence-based renal replacement therapy for acute kidney injury. In: Minerva Anestesiologica. 2009 ; Vol. 75, No. 3. pp. 135-139.
@article{07c1ba3e73844df2863c609c051f898e,
title = "Evidence-based renal replacement therapy for acute kidney injury",
abstract = "Acute kidney injury (AKI) with the subsequent need for renal replacement therapy (RRT) represents a persistent challenge, arising in 4-5{\%} in critically-ill patients, and remains associated with a high mortality (60{\%}) and morbidity. As AKI is an independent risk factor for poor prognosis, appropriate management of patients with AKI becomes of utmost importance. Complications of AKI can be treated with different forms of RRT, such as continuous venovenous hemofiltration or intermittent hemodialysis. However, the timing of the initiation, the modality, and the dose of RRT are still controversial and the subject of ongoing clinical trials. This review presents and discusses currently available data regarding the use of RRT in critically-ill patients with AKI.",
author = "A. Zarbock and K. Singbartl and Kellum, {J. A.}",
year = "2009",
month = "3",
language = "English (US)",
volume = "75",
pages = "135--139",
journal = "Minerva Anestesiologica",
issn = "0375-9393",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

Zarbock, A, Singbartl, K & Kellum, JA 2009, 'Evidence-based renal replacement therapy for acute kidney injury', Minerva Anestesiologica, vol. 75, no. 3, pp. 135-139.

Evidence-based renal replacement therapy for acute kidney injury. / Zarbock, A.; Singbartl, K.; Kellum, J. A.

In: Minerva Anestesiologica, Vol. 75, No. 3, 03.2009, p. 135-139.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - Evidence-based renal replacement therapy for acute kidney injury

AU - Zarbock, A.

AU - Singbartl, K.

AU - Kellum, J. A.

PY - 2009/3

Y1 - 2009/3

N2 - Acute kidney injury (AKI) with the subsequent need for renal replacement therapy (RRT) represents a persistent challenge, arising in 4-5% in critically-ill patients, and remains associated with a high mortality (60%) and morbidity. As AKI is an independent risk factor for poor prognosis, appropriate management of patients with AKI becomes of utmost importance. Complications of AKI can be treated with different forms of RRT, such as continuous venovenous hemofiltration or intermittent hemodialysis. However, the timing of the initiation, the modality, and the dose of RRT are still controversial and the subject of ongoing clinical trials. This review presents and discusses currently available data regarding the use of RRT in critically-ill patients with AKI.

AB - Acute kidney injury (AKI) with the subsequent need for renal replacement therapy (RRT) represents a persistent challenge, arising in 4-5% in critically-ill patients, and remains associated with a high mortality (60%) and morbidity. As AKI is an independent risk factor for poor prognosis, appropriate management of patients with AKI becomes of utmost importance. Complications of AKI can be treated with different forms of RRT, such as continuous venovenous hemofiltration or intermittent hemodialysis. However, the timing of the initiation, the modality, and the dose of RRT are still controversial and the subject of ongoing clinical trials. This review presents and discusses currently available data regarding the use of RRT in critically-ill patients with AKI.

UR - http://www.scopus.com/inward/record.url?scp=66149141350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149141350&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 18475252

AN - SCOPUS:66149141350

VL - 75

SP - 135

EP - 139

JO - Minerva Anestesiologica

JF - Minerva Anestesiologica

SN - 0375-9393

IS - 3

ER -

Zarbock A, Singbartl K, Kellum JA. Evidence-based renal replacement therapy for acute kidney injury. Minerva Anestesiologica. 2009 Mar;75(3):135-139.